MedPath

Comparison of Postprandial Inflammation in Lean and Obese Subjects

Early Phase 1
Completed
Conditions
Nutritional Intervention
Nutritional and Metabolic Diseases
Obesity
Registration Number
NCT01446068
Lead Sponsor
Agroscope Liebefeld-Posieux Research Station ALP
Brief Summary

The purpose of this study is to quantify the systemic inflammatory and metabolic response of lean subjects and obese subjects to the ingestion of three caloric doses of a high-fat meal.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Interleukin-6 (serum)4h vs 0h

A statistically-significant increase in serum Interleukin-6 is expected at 4h compared to 0h

Secondary Outcome Measures
NameTimeMethod
Glucose (serum)0h, 1h, 2h, 4h, 6h
Triglyceride (serum)0h, 1h, 2h, 4h, 6h
Insulin (serum)0h, 1h, 2h, 4h, 6h
high sensitivity C-Reactive Protein0h, 1h, 2h, 4h, 6h
HDL-cholesterol0h, 1h, 2h, 4h, 6h
Total cholesterol0h, 1h, 2h, 4h, 6h
Total cholesterol / HDL cholesterol0h, 1h, 2h, 4h, 6h
Interleukin-6 (serum)0h, 1h, 2h, 4h, 6h
Glucagon-like-protein-1 (serum)0h, 1h 2h, 4h, 6h
Endotoxin (serum)0h, 1h, 2h, 4h, 6h

Trial Locations

Locations (2)

Agroscope Liebefeld-Posieux ALP Research Station

🇨🇭

Berne, Switzerland

University Hospital Inselspital, Berne

🇨🇭

Berne, Switzerland

Agroscope Liebefeld-Posieux ALP Research Station
🇨🇭Berne, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.